Andere Sprachen KALA BIO, Inc. London S.E.

Aktien

A3DWPS

US4831192020

0JQ2

Markt geschlossen - London S.E. Andere Börsenplätze 17:38:57 21.04.2023			% 5 Tage	% 1. Jan.
15,38 ^USD	+4 247,09 %		+126,68 %	+120,22 %

27.06.	Top Mittagsgewinner	MT
27.06.	Sektor-Update: Gesundheitstitel am Donnerstag vorbörslich uneinheitlich	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

KALA BIO, Inc. announced that it has received $12.499192 million in funding from Baker Bros. Advisors LP, ADAR1 Capital Management, LLC, SR One Capital Management, LP	28.06.
Top Midday Gainers	27.06.
Sector Update: Health Care Stocks Mixed Premarket Thursday	27.06.
Kala Bio to Raise $12.5 Million in Private Placement; Shares Jump	27.06.
KALA BIO Announces $12,500,000 Private Placement	27.06.
KALA BIO, Inc. announced that it expects to receive $12.499192 million in funding from Baker Bros. Advisors LP, ADAR1 Capital Management, LLC, SR One Capital Management, LP	26.06.
KALA BIO : Corporate Overview - June 2024	05.06.
KALA BIO to Present at Jefferies Global Healthcare Conference	29.05.
KALA BIO, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14.05.
KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update	14.05.
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	01.04.
KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29.03.
KALA BIO, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29.03.
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	29.03.
KALA BIO, Inc. announced that it expects to receive $8.599799 million in funding from Baker Bros. Advisors LP	25.03.
North American Morning Briefing : Stocks Struggle After New Records	22.03.
North American Morning Briefing : Inflation -2-	15.03.
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference	26.02.
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference	06.02.
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	19.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen KALA BIO, Inc. London S.E.

Aktien

A3DWPS

US4831192020

0JQ2

Andere Sprachen

Filter